One of the newly rising rosacea treatments, botulinum toxin has captivated awareness for its probable efficacy in furnishing up to 4 months of symptomatic relief. Xeomin® seems to show a dose ratio with Botox® of 1:one.33 No substantial distinctions in safety and efficacy are already found in scientific tests comparing Botox® and Xeomin®